NFAT5
Basic information
Region (hg38): 16:69565094-69704666
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFAT5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 185 | 10 | 199 | |||
missense | 357 | 363 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 17 | 20 | ||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 11 | 11 | 2 | 24 | ||
non coding | 27 | 19 | 46 | |||
Total | 0 | 0 | 382 | 219 | 31 |
Variants in NFAT5
This is a list of pathogenic ClinVar variants found in the NFAT5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-69566340-A-C | NFAT5-related disorder | Likely benign (Aug 16, 2022) | ||
16-69568504-A-G | not specified | Uncertain significance (May 27, 2022) | ||
16-69626426-A-G | Uncertain significance (-) | |||
16-69626496-C-T | Uncertain significance (Jul 15, 2022) | |||
16-69647057-A-G | Immunodeficiency | Uncertain significance (Apr 20, 2019) | ||
16-69647058-T-C | not specified | Uncertain significance (Aug 14, 2023) | ||
16-69647062-C-T | Immunodeficiency | Likely benign (Mar 26, 2023) | ||
16-69647063-G-A | Immunodeficiency | Uncertain significance (Apr 17, 2022) | ||
16-69647068-T-C | Immunodeficiency | Likely benign (Jul 12, 2022) | ||
16-69647099-A-G | Immunodeficiency • not specified | Uncertain significance (Oct 29, 2023) | ||
16-69647100-C-T | Immunodeficiency | Uncertain significance (Jul 05, 2022) | ||
16-69647101-C-T | Immunodeficiency | Likely benign (Oct 23, 2022) | ||
16-69647109-C-G | not specified | Uncertain significance (Jun 22, 2023) | ||
16-69647113-C-T | Immunodeficiency | Likely benign (Dec 23, 2020) | ||
16-69647115-C-T | Immunodeficiency | Uncertain significance (Nov 21, 2023) | ||
16-69647120-A-G | Immunodeficiency | Uncertain significance (Oct 05, 2020) | ||
16-69647122-C-A | Immunodeficiency | Likely benign (Jan 18, 2023) | ||
16-69647123-G-A | Immunodeficiency | Uncertain significance (May 01, 2023) | ||
16-69647125-C-T | Immunodeficiency | Likely benign (Jul 03, 2023) | ||
16-69647135-A-T | Immunodeficiency | Uncertain significance (Oct 21, 2020) | ||
16-69647146-G-C | Immunodeficiency | Uncertain significance (Aug 20, 2021) | ||
16-69647161-C-T | Immunodeficiency | Likely benign (Nov 24, 2023) | ||
16-69647162-G-A | Immunodeficiency | Benign (Sep 23, 2022) | ||
16-69647164-G-T | Immunodeficiency | Likely benign (Jul 03, 2022) | ||
16-69647176-C-G | not specified | Uncertain significance (Mar 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NFAT5 | protein_coding | protein_coding | ENST00000432919 | 14 | 139573 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000192 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.13 | 537 | 784 | 0.685 | 0.0000379 | 10215 |
Missense in Polyphen | 171 | 324.28 | 0.52732 | 4316 | ||
Synonymous | 1.13 | 263 | 287 | 0.915 | 0.0000149 | 2991 |
Loss of Function | 7.15 | 9 | 76.4 | 0.118 | 0.00000417 | 804 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000294 | 0.0000294 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000894 | 0.000870 |
Finnish | 0.0000959 | 0.0000924 |
European (Non-Finnish) | 0.0000849 | 0.0000791 |
Middle Eastern | 0.000894 | 0.000870 |
South Asian | 0.0000368 | 0.0000327 |
Other | 0.000190 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Binds the DNA consensus sequence 5'- [ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). {ECO:0000269|PubMed:10051678, ECO:0000269|PubMed:10377394, ECO:0000269|PubMed:22266867}.;
Recessive Scores
- pRec
- 0.302
Intolerance Scores
- loftool
- 0.439
- rvis_EVS
- -1.37
- rvis_percentile_EVS
- 4.45
Haploinsufficiency Scores
- pHI
- 0.855
- hipred
- Y
- hipred_score
- 0.532
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.514
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nfat5
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- nfat5a
- Affected structure
- pericardium
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- cytokine production;transcription by RNA polymerase II;signal transduction;excretion;calcineurin-NFAT signaling cascade;positive regulation of transcription by RNA polymerase II;regulation of calcineurin-NFAT signaling cascade;cellular response to cytokine stimulus;positive regulation of NIK/NF-kappaB signaling;positive regulation of leukocyte adhesion to vascular endothelial cell
- Cellular component
- nucleus;nucleoplasm;transcription factor complex;cytosol;nuclear transcription factor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding